Lower Cannabis Cue Bias in High-CBD Users Did Not Establish Lower Future Dependence

A naturalistic study summarized in the historical CBD review found lower cannabis-cue bias, liking and wanting among users of higher-CBD cannabis. Those measurements did not directly establish a lower future incidence of dependence.

The study measured responses related to drug interest

The review describes a comparison between users choosing cannabis with relatively high or low CBD-to-THC ratios. Higher CBD content was associated with weaker attentional bias toward cannabis-related stimuli and lower appreciation and desire for the selected drug. These observations concern attention and subjective drug responses at the assessment.

A risk hypothesis differs from a measured clinical outcome

Cue bias, liking and wanting can inform hypotheses about reinforcement and dependence. They are not identical to observing the subsequent onset of a substance-use disorder. The review itself calls for further investigation of whether differences between real-world products translate into different addiction risks. A prospective clinical conclusion therefore goes beyond the measurements summarized here.

Product choice adds confounding

Participants selected products rather than being randomly assigned CBD independently of THC and personal preference. The groups could differ in use history, reasons for choosing cannabis and other characteristics. This study also differs from a later controlled challenge asking whether added CBD changes THC-related cue responding. Its specific contribution is a historical naturalistic association, not a validated dependence-prevention intervention or proof that a higher-CBD product eliminates addiction risk.

Related analysis: the broader evidence and its limitations.

Research cited

This analysis uses the supplied review; individual experiments are discussed as summarized there: Niesink and van Laar (2013). Does cannabidiol protect against adverse psychological effects of THC?

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A small MS trial summarized in the early human CBD review reported more adverse events with a CBD-containing cannabis extract than with THC alone. The combination did not demonstrate a general safety advantage. The study had a defined clinical comparison The review describes a four-week crossover study involving 16 patients…

Spread the love

Read Article: Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A cancer-related anorexia trial summarized in the early human CBD review was terminated at interim analysis because the study arms did not differ. Its combination treatment did not supply positive appetite-treatment evidence in that comparison. The trial compared more than one active preparation The review describes 243 patients assigned to…

Spread the love

Read Article: A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

A small historical crossover experiment summarized in the human CBD review reported marginal reductions in nabilone-related intoxication and binocular depth-perception impairment. It did not establish broad protection against synthetic-cannabinoid effects. The comparison involved a specific synthetic cannabinoid Nine male participants received oral CBD at 200 mg, alone and with nabilone…

Spread the love

Read Article: A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us